NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

I'll consider it worldwide after the 4 regulators we're working with have approved, as others will accept that without further trials,

I would consider US , Japan and EU to be the drivers of worldwide RA acceptance.. After that the rest are paperwork and price negotiation (or, in some case, bribes).

Both Canada and UK are minor players on the board,.

The issue with MHRA is not technical competency , it is that NICE drives the price down so hard that no BP cares about the market much. It is an afterthought.

And Canada is just a follower. They will approve when others have.